Association Between Bleeding and New Cancer Detection and the Prognosis in Patients With Myocardial Infarction
Youngcheol Ahn, Dongjae Lee, Eun Ho Choo, Ik Jun Choi, Sungmin Lim, Kwan Yong Lee, Byung-Hee Hwang, Mahn-Won Park, Jong-Min Lee, Chul Soo Park, Hee-Yeol Kim, Ki-Dong Yoo, Doo Soo Jeon, Wook Sung Chung, Min Chul Kim, Myung Ho Jeong, Youngkeun Ahn, Kiyuk Chang, Youngcheol Ahn, Dongjae Lee, Eun Ho Choo, Ik Jun Choi, Sungmin Lim, Kwan Yong Lee, Byung-Hee Hwang, Mahn-Won Park, Jong-Min Lee, Chul Soo Park, Hee-Yeol Kim, Ki-Dong Yoo, Doo Soo Jeon, Wook Sung Chung, Min Chul Kim, Myung Ho Jeong, Youngkeun Ahn, Kiyuk Chang
Abstract
Background Antithrombotic agents to treat patients with acute myocardial infarction can cause bleeding, which may reveal undiagnosed cancer. However, the relationship between bleeding and new cancer diagnosis and the prognostic impact is still unclear. Methods and Results We analyzed the new cancer diagnosis, Bleeding Academic Research Consortium 2, 3, or 5 bleeding, and all-cause death of 10 364 patients with acute myocardial infarction without a history of previous cancer in a multicenter acute myocardial infarction registry. During a median of 4.9 years, 1109 patients (10.7%) experienced Bleeding Academic Research Consortium 2, 3, or 5 bleeding, and 338 patients (3.3%) were newly diagnosed with cancer. Bleeding Academic Research Consortium 2, 3, or 5 bleeding was associated with an increased risk of new cancer diagnosis (subdistribution hazard ratio [sHR] 3.29 [95% CI, 2.50-4.32]). In particular, there were robust associations between gastrointestinal bleeding and new gastrointestinal cancer diagnosis (sHR, 19.96 [95% CI, 11.30-29.94]) and between genitourinary bleeding and new genitourinary cancer diagnosis (sHR, 28.95 [95% CI, 14.69-57.07]). The risk of all-cause death was not lower in patients diagnosed with new gastrointestinal cancer after gastrointestinal bleeding (hazard ratio [HR], 4.05 [95% CI, 2.04-8.02]) and diagnosed with new genitourinary cancer after genitourinary bleeding (HR, 2.79 [95% CI, 0.81-9.56]) than in patients newly diagnosed with cancer without previous bleeding. Conclusions Clinically significant bleeding, especially gastrointestinal and genitourinary bleeding, in patients with AMI was associated with an increased risk of new cancer diagnoses. However, the bleeding preceding new cancer detection was not associated with better survival. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT02385682 and NCT02806102.
Keywords: bleeding; cancer; gastrointestinal cancer; myocardial infarction; urogenital cancer.
Figures
References
- Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE‐DAPT) score: a pooled analysis of individual‐patient datasets from clinical trials. Lancet. 2017;389:1025–1034. doi: 10.1016/s0140-6736(17)30397-5
- Genereux P, Giustino G, Witzenbichler B, Weisz G, Stuckey TD, Rinaldi MJ, Neumann FJ, Metzger DC, Henry TD, Cox DA, et al. Incidence, predictors, and impact of post‐discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol. 2015;66:1036–1045. doi: 10.1016/j.jacc.2015.06.1323
- Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, et al. Coronary thrombosis and major bleeding after PCI with drug‐eluting stents: risk scores from PARIS. J Am Coll Cardiol. 2016;67:2224–2234. doi: 10.1016/j.jacc.2016.02.064
- Raposeiras‐Roubín S, Faxén J, Íñiguez‐Romo A, Henriques JPS, D'Ascenzo F, Saucedo J, Szummer K, Jernberg T, James SK, Juanatey JRG, et al. Development and external validation of a post‐discharge bleeding risk score in patients with acute coronary syndrome: the BleeMACS score. Int J Cardiol. 2018;254:10–15. doi: 10.1016/j.ijcard.2017.10.103
- Serebruany VL, Cherepanov V, Cabrera‐Fuentes HA, Kim MH. Solid cancers after antiplatelet therapy: confirmations, controversies, and challenges. Thromb Haemost. 2015;114:1104–1112. doi: 10.1160/TH15-01-0077
- Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, Henry TD, Kini AS, Stuckey T, Cohen DJ, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet. 2013;382:1714–1722. doi: 10.1016/s0140-6736(13)61720-1
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli‐Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST‐segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177. doi: 10.1093/eurheartj/ehx393
- Collet JP, Thiele H, Barbato E, Barthélémy O, Bauersachs J, Bhatt DL, Dendale P, Dorobantu M, Edvardsen T, Folliguet T, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST‐segment elevation. Eur Heart J. 2021;42:1289–1367. doi: 10.1093/eurheartj/ehaa575
- Choi IJ, Lim S, Choo EH, Hwang BH, Kim CJ, Park MW, Lee JM, Park CS, Kim HY, Yoo KD, et al. Impact of intravascular ultrasound on long‐term clinical outcomes in patients with acute myocardial infarction. JACC: Cardiovasc Interv. 2021;14:2431–2443. doi: 10.1016/j.jcin.2021.08.021
- Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Thygesen K, Alpert JS, White HD, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–1598. doi: 10.1016/j.jacc.2012.08.001
- Viborg S, Sogaard KK, Farkas DK, Norrelund H, Pedersen L, Sorensen HT. Lower gastrointestinal bleeding and risk of gastrointestinal cancer. Clin Transl Gastroenterol. 2016;7:e162. doi: 10.1038/ctg.2016.16
- Nielsen M, Qaseem A. High value care task force of the American College of P. hematuria as a marker of occult urinary tract cancer: advice for high‐value care from the American College of Physicians. Ann Intern Med. 2016;164:488–497. doi: 10.7326/M15-1496
- Norgaard M, Veres K, Ording AG, Djurhuus JC, Jensen JB, Sorensen HT. Evaluation of hospital‐based hematuria diagnosis and subsequent cancer risk among adults in Denmark. JAMA Netw Open. 2018;1:e184909. doi: 10.1001/jamanetworkopen.2018.4909
- Clarke MA, Long BJ, Del Mar MA, Arbyn M, Bakkum‐Gamez JN, Wentzensen N. Association of endometrial cancer risk with postmenopausal bleeding in women: a systematic review and meta‐analysis. JAMA Intern Med. 2018;178:1210–1222. doi: 10.1001/jamainternmed.2018.2820
- Eikelboom JW, Connolly SJ, Bosch J, Shestakovska O, Aboyans V, Alings M, Anand SS, Avezum A, Berkowitz SD, Bhatt DL, et al. Bleeding and new cancer diagnosis in patients with atherosclerosis. Circulation. 2019;140:1451–1459. doi: 10.1161/CIRCULATIONAHA.119.041949
- Raposeiras‐Roubin S, Abu‐Assi E, Munoz‐Pousa I, Rossello X, Cespon‐Fernandez M, Melendo Viu M, Caneiro‐Queija B, Cobas‐Paz R, Bastos G, Iniguez‐Romo A. Usefulness of bleeding after acute coronary syndromes for unmasking silent cancer. Am J Cardiol. 2020;125:1801–1808. doi: 10.1016/j.amjcard.2020.03.023
- Chang TY, Chan YH, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, et al. Risks and outcomes of gastrointestinal malignancies in anticoagulated atrial fibrillation patients experiencing gastrointestinal bleeding: a nationwide cohort study. Heart Rhythm. 2020;17:1745–1751. doi: 10.1016/j.hrthm.2020.05.026
- Raposeiras Roubin S, Abu Assi E, Barreiro Pardal C, Cespon Fernandez M, Munoz Pousa I, Cobas Paz R, Parada JA, Represa Montenegro M, Melendo Miu M, Blanco Prieto S, et al. New cancer diagnosis after bleeding in anticoagulated patients with atrial fibrillation. J Am Heart Assoc. 2020;9:e016836. doi: 10.1161/JAHA.120.016836
- Conen D, Wong JA, Sandhu RK, Cook NR, Lee IM, Buring JE, Albert CM. Risk of malignant cancer among women with new‐onset atrial fibrillation. JAMA Cardiol. 2016;1:389–396. doi: 10.1001/jamacardio.2016.0280
- Velders MA, Hagstrom E, James SK. Temporal trends in the prevalence of cancer and its impact on outcome in patients with first myocardial infarction: a Nationwide study. J Am Heart Assoc. 2020;9:e014383. doi: 10.1161/JAHA.119.014383
- Roe MT, Strickler J. Addressing the conundrum of bleeding and cancer detection with antithrombotic therapies for chronic atherosclerotic cardiovascular disease. Circulation. 2019;140:1460–1462. doi: 10.1161/CIRCULATIONAHA.119.042875
- Andreotti F, Maggioni AP. Cancer unmasked by bleeding during anticoagulant therapy: when a problem may become an opportunity. Eur Heart J. 2020;43:e45–e47. doi: 10.1093/eurheartj/ehaa164
- Mauri L, Elmariah S, Yeh RW, Cutlip DE, Steg PG, Windecker S, Wiviott SD, Cohen DJ, Massaro JM, D'Agostino RB Sr, et al. Causes of late mortality with dual antiplatelet therapy after coronary stents. Eur Heart J. 2016;37:378–385. doi: 10.1093/eurheartj/ehv614
Source: PubMed